Treating cervical cancer: Breast and Cervical Cancer Prevention and Treatment Act patients

• Published in: American journal of obstetrics and gynecology Vol. 204; no. 6; pp. 533.e1 - 533.e8
• Main Authors: Chien, Li-Nien, PhD, Adams, E. Kathleen, PhD, Flowers, Lisa C., MD
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.06.2011; Elsevier
• Subjects: Adult; BCCPTA; Biological and medical sciences; cancer treatment; cervical cancer; Female; Female genital diseases; Georgia; Gynecology. Andrology. Obstetrics; Humans; Mammary gland diseases; Medicaid; Medical sciences; Middle Aged; Obstetrics and Gynecology; Pregnancy; Tumors; United States; Uterine Cervical Neoplasms - therapy; Young Adult; United States; Georgia; cancer treatment; BCCPTA; Medicaid; cervical cancer; Human; Breast disease; Gynecology; Breast cancer; Malignant tumor; Obstetrics; Female genital diseases; Prevention; Mammary gland diseases; Treatment; Uterine cervix diseases; Cervical cancer; Cancer
• ISSN: 0002-9378; 1097-6868
• DOI: 10.1016/j.ajog.2011.01.033

Objective To investigate cervical cancer treatment of patients enrolled under the Breast and Cervical Cancer Prevention and Treatment Act in Georgia. Study Design Georgia Comprehensive Cancer Registry and Medicaid enrollment/claims were used to identify enrollees with preinvasive disease (n = 1149) and invasive cervical cancer (n = 444). Logistic regressions were used to estimate factors associated with the odds of receiving: (1) cancer workup, (2) precancerous procedure, (3) surgery, (4) radiation, and (5) chemotherapy. Results Preinvasive disease cases with cervical intraepithelial neoplasia 3, in situ, a comorbidity or without a Commission on Cancer approved hospital nearby were more likely to receive surgery. Among invasive cases, later stage was associated with higher odds of receiving radiation or chemotherapy. Black patients were less likely to have surgery than white patients regardless of preinvasive ( P < .01) or invasive status ( P = .05). Conclusion Treatment patterns among Georgia Medicaid cases appear appropriate to stage but 18% with invasive cervical cancer received no cancer treatment, although Medicaid enrolled.